mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-06 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |